Literature DB >> 10603220

Dengue seroconversion among Israeli travelers to tropical countries.

I Potasman1, I Srugo, E Schwartz.   

Abstract

We tested for dengue seroconversion among 104 Israeli young adults who traveled to tropical countries for at least 3 months. Seven (6. 7%) seroconverted during travel; four (3.8%) had immunoglobulin (Ig) M antibodies; one was symptomatic with borderline IgM and a rise in IgG; two others (1.9%) had a rise in IgG titers, without detectable IgM. All four IgM-positive patients had traveled to Southeast Asia.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10603220      PMCID： PMC2640810          DOI： 10.3201/eid0506.990615

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  17 in total

1.  Dengue vector mosquitos at a tourist attraction, Ko Samui, in 1995.

Authors:  U Thavara; A Tawatsin; P Phan-Urai; W Ngamsuk; C Chansang; M Liu; Z Li
Journal:  Southeast Asian J Trop Med Public Health       Date:  1996-03       Impact factor: 0.267

2.  A prospective study of dengue infections in Bangkok.

Authors:  D S Burke; A Nisalak; D E Johnson; R M Scott
Journal:  Am J Trop Med Hyg       Date:  1988-01       Impact factor: 2.345

3.  Illness associated with "package tours": a combined Spanish-Scottish study.

Authors:  D Reid; N R Grist; R Nájera
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

4.  Health problems after travel to developing countries.

Authors:  R Steffen; M Rickenbach; U Wilhelm; A Helminger; M Schär
Journal:  J Infect Dis       Date:  1987-07       Impact factor: 5.226

5.  [Health concerns of Israelis traveling to Third World countries--experience of a travel advisory clinic].

Authors:  S A Berger; M Giladi; I Shapira
Journal:  Harefuah       Date:  1994-04-01

6.  Mosquitoes, models, and dengue.

Authors:  A R Lifson
Journal:  Lancet       Date:  1996-05-04       Impact factor: 79.321

7.  [Laboratory virological diagnosis of imported dengue cases].

Authors:  S Yabe; M Nakayama; K Yamada; T Kitano; Y Arai; T Horimoto; G Masuda; A Mitou; M Tashiro
Journal:  Kansenshogaku Zasshi       Date:  1996-11

8.  Studies on serological cross-reaction in sequential flavivirus infections.

Authors:  Y Makino; M Tadano; M Saito; N Maneekarn; N Sittisombut; V Sirisanthana; B Poneprasert; T Fukunaga
Journal:  Microbiol Immunol       Date:  1994       Impact factor: 1.955

Review 9.  Mosquitoes and mosquito repellents: a clinician's guide.

Authors:  M S Fradin
Journal:  Ann Intern Med       Date:  1998-06-01       Impact factor: 25.391

10.  [Imported dengue fever in Switzerland--serological evidence for a hitherto unexpectedly high prevalence].

Authors:  S G Settah; P L Vernazza; R Morant; D Schultze
Journal:  Schweiz Med Wochenschr       Date:  1995-09-09
View more
  33 in total

Review 1.  Dengue: an escalating problem.

Authors:  Robert V Gibbons; David W Vaughn
Journal:  BMJ       Date:  2002-06-29

2.  Incidence and seroprevalence of dengue virus infections in Australian travellers to Asia.

Authors:  I Ratnam; J Black; K Leder; B-A Biggs; E Matchett; A Padiglione; I Woolley; T Panagiotidis; T Gherardin; L Pollissard; C Demont; C Luxemburger; J Torresi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-09       Impact factor: 3.267

3.  Dengue virus immunoglobulin M detection in a reference laboratory setting during the 2010 dengue virus outbreak on Caribbean islands.

Authors:  Harry E Prince; Jose L Matud; Jay M Lieberman
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

4.  Primary and probable secondary dengue virus (DV) infection rates in relation to age among DV IgM-positive patients residing in the United States mainland versus the Caribbean islands.

Authors:  Harry E Prince; Cindy Yeh; Mary Lapé-Nixon
Journal:  Clin Vaccine Immunol       Date:  2011-11-23

5.  Mosquito Exposure and Chikungunya and Dengue Infection Among Travelers During the Chikungunya Outbreak in the Americas.

Authors:  David A Lindholm; Todd Myers; Susana Widjaja; Edward M Grant; Kalyani Telu; Tahaniyat Lalani; Jamie Fraser; Mary Fairchok; Anuradha Ganesan; Mark D Johnson; Anjali Kunz; David R Tribble; Heather C Yun
Journal:  Am J Trop Med Hyg       Date:  2017-01-23       Impact factor: 2.345

6.  Dengue Virus Seroconversion in Travelers to Dengue-Endemic Areas.

Authors:  Rosemary M Olivero; Davidson H Hamer; William B MacLeod; Christine M Benoit; Carolina Sanchez-Vegas; Emily S Jentes; Lin H Chen; Mary E Wilson; Nina Marano; Emad A Yanni; Winnie W Ooi; Adolf W Karchmer; Laura Kogelman; Elizabeth D Barnett
Journal:  Am J Trop Med Hyg       Date:  2016-08-29       Impact factor: 2.345

7.  Dengue risk among visitors to Hawaii during an outbreak.

Authors:  Carrie E Smith; Tammy Tom; Jed Sasaki; Tracy Ayers; Paul V Effler
Journal:  Emerg Infect Dis       Date:  2005-05       Impact factor: 6.883

8.  Dengue infections in non-immune travellers to Thailand.

Authors:  E Massad; J Rocklov; A Wilder-Smith
Journal:  Epidemiol Infect       Date:  2012-04-24       Impact factor: 4.434

9.  Illness in long-term travelers visiting GeoSentinel clinics.

Authors:  Lin H Chen; Mary E Wilson; Xiaohong Davis; Louis Loutan; Eli Schwartz; Jay Keystone; Devon Hale; Poh Lian Lim; Anne McCarthy; Effrossyni Gkrania-Klotsas; Patricia Schlagenhauf
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

10.  Immunogenicity and safety of a tetravalent dengue vaccine in dengue-naïve adolescents in Mexico City.

Authors:  Shibadas Biswal; Jorge Fernando Mendez Galvan; Mercedes Macias Parra; Juan-Francisco Galan-Herrera; Monica Belisa Carrascal Rodriguez; Esteban Patricio Rodriguez Bueno; Manja Brose; Martina Rauscher; Inge LeFevre; Derek Wallace; Astrid Borkowski
Journal:  Rev Panam Salud Publica       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.